patients with the study drug, hydroxychloroquine, along with IL-2, a standard treatment of
kidney cancer that has spread to other parts of the body, can make the cancer easier to kill
and eliminate. Another goal is to see how the study drug affects the body''s immune cells
which fight cancer cells.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: email@example.com
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.